Biomarker Technologies LLC Seeking Series A Funds For Clinical Studies On New Blood Test For Breast Cancer
10/19/2005 5:13:09 PM
PHOENIX--(BUSINESS WIRE)--April 19, 2005--Biomarker Technologies LLC, the worldwide technology provider of the BT Test(TM), a blood diagnostic for the detection of breast cancer, announced today it is seeking to raise Series A Funding to conduct clinical studies of the in-vitro diagnostic test for subsequent FDA approval.
The company received initial funding in 2004 from angel investors and is in due diligence with numerous potential licensees.
comments powered by